Compare KTB & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KTB | ADMA |
|---|---|---|
| Founded | 2018 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.6B |
| IPO Year | 2018 | 2012 |
| Metric | KTB | ADMA |
|---|---|---|
| Price | $72.00 | $9.70 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 2 |
| Target Price | ★ $99.67 | $32.00 |
| AVG Volume (30 Days) | 642.4K | ★ 9.1M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.91% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 4.05 | 0.60 |
| Revenue | ★ $2,097,839,000.00 | $42,219,783.00 |
| Revenue This Year | $10.39 | $27.46 |
| Revenue Next Year | $3.91 | $22.11 |
| P/E Ratio | $18.00 | ★ $16.53 |
| Revenue Growth | N/A | ★ 43.85 |
| 52 Week Low | $53.15 | $7.21 |
| 52 Week High | $87.00 | $25.67 |
| Indicator | KTB | ADMA |
|---|---|---|
| Relative Strength Index (RSI) | 55.75 | 32.56 |
| Support Level | $69.58 | $7.21 |
| Resistance Level | $71.97 | $16.44 |
| Average True Range (ATR) | 2.77 | 0.99 |
| MACD | 0.29 | 0.07 |
| Stochastic Oscillator | 64.26 | 34.27 |
Kontoor Brands Inc is a lifestyle apparel company. It designs, manufactures, procures, sells, and licenses apparel, footwear, and accessories, mainly under the brand names Wrangler, Lee, Helly Hansen, and a few other brands. The company also licenses the use of its brands in certain regions. Its products are sold through wholesale and direct-to-consumer channels in the United States (its key revenue-generating market) and internationally, mainly in Europe, Middle East and Africa (EMEA), Asia-Pacific (APAC), and Non-U.S. Americas regions. The company's three reportable segments are Wrangler, Lee, and Helly Hansen. The majority of its revenue is generated from the Wrangler segment, which offers denim, apparel, footwear, and accessories through Wrangler and various sub-brands.
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.